Next-Generation Photon-Counting CT Technology: Development and Clinical Evaluation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-89
SponsorUniversity of Pennsylvania
About this trial
This project aims to develop and evaluate a next-generation photon-counting CT prototype, and assess whether next-generation photon-counting CT--which enables reduced radiation dose, high spatial resolution, and spectral imaging--would facilitate improved diagnostic performance for abdominal, cardiothoracic, musculoskeletal, and neuroimaging.
Eligibility criteria
Qualifiers
Age 18 to 89.
Participants must be informed of the investigational nature of this study and be willing to provide written informed consent and participate in this study in accordance with institutional and federal guidelines prior to study-specific procedures.
Not pregnant (based on attestation)
Disqualifiers
Pregnant women will not be included. All females of childbearing potential must attest that they are not pregnant before CT imaging.
Participants with a known contrast allergy.
Any current medical condition, illness, or disorder, as assessed by medical record review and/or self-reported, that is considered by a physician investigator to be a condition that could compromise participant safety or successful participation in the study.
Trial design
Treatments tested in this trial
- CT-DACE
Treatment groups
No treatment groups listed
Sponsors and collaborators
University of Pennsylvania
Lead sponsor
Canon Medical Systems, USA
Collaborator
Source ClinicalTrials.gov